SCHEMBL463519

SCHEMBL463519

Cc1cc([C@H]2CN(Cc3ccccc3)C[C@@H]2NC(=O)OC(C)(C)C)c(F)cc1F

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
POLB P06746 1/20 0.39
PDE4B Q07343 1/20 0.39
KDM1A O60341 1/20 0.39
MAOB P27338 1/20 0.39
DRD2 P14416 4/20 0.38
DRD4 P21917 4/20 0.38
DRD3 P35462 4/20 0.38
SCN4A P35499 2/20 0.38
DPP4 P27487 1/20 0.38
SCN9A Q15858 1/20 0.38
CHRM2 P08172 1/20 0.38
MC1R Q01726 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
CACNA1G O43497 1/20 0.38
JAK1 P23458 1/20 0.37
NPFFR1 Q9GZQ6 1/20 0.37
NPFFR2 Q9Y5X5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL463520 1.00 KMT2A (0.44) KMT2AL3MBTL1POLBPDE4BKDM1A
SCHEMBL147896 0.93 L3MBTL1 (0.46) KMT2AL3MBTL1PDE4BKDM1AMAOB
SCHEMBL147897 0.93 L3MBTL1 (0.46) KMT2AL3MBTL1PDE4BKDM1AMAOB
SCHEMBL147898 0.93 L3MBTL1 (0.46) KMT2AL3MBTL1PDE4BKDM1AMAOB
SCHEMBL459499 0.89 KMT2A (0.44) KMT2AL3MBTL1PDE4BKDM1AMAOB
SCHEMBL459501 0.89 KMT2A (0.44) KMT2AL3MBTL1PDE4BKDM1AMAOB
SCHEMBL143625 0.88 MC1R (0.49) KMT2AL3MBTL1DRD2DRD3MC1R
SCHEMBL147672 0.88 KMT2A (0.48) KMT2AL3MBTL1DRD2DRD3DPP4
SCHEMBL143626 0.88 MC1R (0.49) KMT2AL3MBTL1DRD2DRD3MC1R
SCHEMBL147670 0.88 KMT2A (0.48) KMT2AL3MBTL1DRD2DRD3DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013026587-A1 1,4 DISUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2013-02-28 WO disclosed
WO-2011147951-A1 CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS PROSIDION LIMITED (GB) 2011-12-01 WO disclosed
WO-2011147951-A1 CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS PROSIDION LIMITED (GB) 2011-12-01 WO disclosed